Zenith markets a prompt phenytoin sodium capsule, and it should not be substituted for extended phenytoin. In a companion paper, Mylan's formulation of extended-release phenytoin sodium produced a ...

The Competition and Markets Authority (CMA) found the companies had broken competition rules by increasing the price of phenytoin sodium capsules in 2012 after “de-branding” the drug.

Pfizer and Flynn Pharma, manufacturers of phenytoin sodium capsules which are used to treat epilepsy, have been fined a combined total of £69 million by the Competitions Appeal Tribunal (CAT) for ...

Consideration should be given to the type of EN formulation administered concurrently with phenytoin ... of extended-release carbamazepine capsules through the feeding tube in children.

The CMA delivered a preliminary judgment in the case last year which concluded that Pfizer and Flynn abused a dominant position in phenytoin sodium capsules, causing NHS spending on the drug to ...

The U.K. Competition Appeal Tribunal (CAT) has imposed its own fines on Pfizer and Flynn Pharma for abusing their dominant positions by ...